Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sabinsa Granted Canadian Health Claim on IBS for LactoSpore - Nutraceuticals World
Regulations

Sabinsa Granted Canadian Health Claim on IBS for LactoSpore

The probiotic strain was awarded the claim, “Helps relieve abdominal pain associated with IBS (Irritable Bowel Syndrome).”

Health Canada, the federal department that regulates the products that help the people of Canada maintain and improve their health, has issued a Product License to Sabinsa, East Windsor, NJ, for a significant health claim on LactoSpore Balance: “Helps relieve abdominal pain associated with IBS (Irritable Bowel Syndrome).” The strain is LactoSpore MTCC 5856.
 
“This health claim was based on the IBS clinical study we did for LactoSpore,” said Shaheen Majeed, Sabinsa’s marketing director. “It gives us great validation for the clinical work we’re doing globally.”
 
While LactoSpore has been on the market for over 20 years, emerging clinical evidence on LactoSpore has moved the focus beyond maintaining gut health into sports nutrition, cognitive health, IBS and related gut health conditions. Sabinsa obtained self-affirmed GRAS status for LactoSpore in the U.S. in 2008, with LactoSpore’s intended market reach clearly listed, and included foods, beverages, chocolate, confectionaries such as gummies and soft candies, yogurts and soups. LactoSpore has also found applications in whey protein supplements, a staple of the sports nutrition market. Earlier in 2016, U.S.-FDA submitted their no questions GRAS letter for Sabinsa’s LactoSpore as well.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters